Maarten I. Beekman

The Hague, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Correction to: The Association Between Short-Acting β2-Agonist Over-Prescription, and Patient-Reported Acquisition and Use on Asthma Control and Exacerbations: Data from Australia.

Correction to: The Association Between Short-Acting β2-Agonist Over-Prescription, and Patient-Reported Acquisition and Use on Asthma Control and Exacerbations: Data from Australia.

Journal: Advances in therapy

Published: September 26, 2025

SABA prescriptions and asthma management practices in Singapore: results from a cross-sectional, observational SABINA III study.

SABA prescriptions and asthma management practices in Singapore: results from a cross-sectional, observational SABINA III study.

Journal: BMJ open

Published: June 10, 2024

Over-the-counter short-acting β2-agonist purchase and asthma-related health outcomes: a post hoc analysis of the SABINA III study.

Over-the-counter short-acting β2-agonist purchase and asthma-related health outcomes: a post hoc analysis of the SABINA III study.

Journal: NPJ primary care respiratory medicine

Published: June 07, 2024

The Association Between Short-Acting β2-Agonist Over-Prescription, and Patient-Reported Acquisition and Use on Asthma Control and Exacerbations: Data from Australia.

The Association Between Short-Acting β2-Agonist Over-Prescription, and Patient-Reported Acquisition and Use on Asthma Control and Exacerbations: Data from Australia.

Journal: Advances in therapy

Published: August 03, 2023

Short-acting β2-agonist prescription patterns in patients with asthma treated by specialists in Thailand: results from SABINA III.

Short-acting β2-agonist prescription patterns in patients with asthma treated by specialists in Thailand: results from SABINA III.

Journal: The Journal of asthma : official journal of the Association for the Care of Asthma

Published: July 05, 2023

Overprescription of short-acting β2 agonists: reflections from the SABINA study in Brazil.

Overprescription of short-acting β2 agonists: reflections from the SABINA study in Brazil.

Journal: Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia

Published: March 30, 2023

Short-acting β2-agonist prescriptions in patients with asthma: findings from the South Korean cohort of SABINA III.

Short-acting β2-agonist prescriptions in patients with asthma: findings from the South Korean cohort of SABINA III.

Journal: The Korean journal of internal medicine

Published: February 23, 2023

Toward a better understanding of severe asthma phenotypes in Latin America: results from the PREPARE study.

Toward a better understanding of severe asthma phenotypes in Latin America: results from the PREPARE study.

Journal: Current medical research and opinion

Published: February 06, 2023

Short-acting β2-agonists over-prescription in patients with asthma: an Indian subset analysis of international SABINA III study.

Short-acting β2-agonists over-prescription in patients with asthma: an Indian subset analysis of international SABINA III study.

Journal: The Journal of asthma : official journal of the Association for the Care of Asthma

Published: December 15, 2022

Evaluation of short-acting Beta-2-agonist prescriptions and associated clinical outcomes: Findings from the SABA use IN Asthma (SABINA) study in Asia.

Evaluation of short-acting Beta-2-agonist prescriptions and associated clinical outcomes: Findings from the SABA use IN Asthma (SABINA) study in Asia.

Journal: The World Allergy Organization journal

Published: November 03, 2022

Short-acting beta-2 agonist prescription patterns and clinical outcomes in Chinese patients with asthma: an observational study in mainland China for the SABINA programme.

Short-acting beta-2 agonist prescription patterns and clinical outcomes in Chinese patients with asthma: an observational study in mainland China for the SABINA programme.

Journal: Therapeutic advances in respiratory disease

Published: September 06, 2022

Over-prescription of short-acting β2-agonists is associated with poor asthma outcomes: results from the African cohort of the SABINA III study.

Over-prescription of short-acting β2-agonists is associated with poor asthma outcomes: results from the African cohort of the SABINA III study.

Journal: Current medical research and opinion

Published: August 29, 2022

Showing 1-12 of 25

Last Updated: 09/26/2026